|
|
|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
|
|
|
MANUFACTURER:
|
|
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
B
|
|
INDICATIONS:
|
|
Anesthesia, local |
|
Anesthesia, regional |
| |
|
|
SIDE EFFECTS:
|
|
Hypotension |
|
nausea |
|
Back pain |
|
bradycardia |
|
fever |
|
headache |
|
pain |
|
paresthesia |
|
vomiting |
|
Anxiety |
|
blurred vision |
|
chills |
|
dizziness |
|
drowsiness |
|
incoherent speech |
|
metallic taste |
|
numbness and tingling of mouth or lips |
|
pruritus |
|
restlessness |
|
tremors |
|
twitching |
|
urinary retention |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
>> Cardiovascular function impairment |
|
>> Hepatic function impairment |
|
Renal function impairment |
|
|
ADULT DOSE:
|
|
Central neural blocks-
Lumbar epidural-
Anesthesia, surgical:
75 to 150 mg of 0.5% (5 mg per mL) solution, administered in incremental doses.
113 to 188 mg of 0.75% (7.5 mg per mL) solution, administered in incremental doses.
150 to 200 mg of 1% (10 mg per mL) solution, administered in incremental doses.
Anesthesia, surgical, cesarean section:
100 to 150 mg of 0.5% (5 mg per mL) solution, administered in incremental doses .
Pain, obstetrical:
20 to 40 mg of 0.2% (2 mg per mL) solution initially, then 12 to 28 mg per hour as a continuous infusion or 20 to 30 mg per hour, administered in incremental doses .
Pain, postoperative:
Continuous infusion, 12 to 20 mg of 0.2% (2 mg per mL) solution per hour .
Thoracic epidural-
Anesthesia, surgical:
25 to 75 mg of 0.5% (5 mg per mL) solution, administered in incremental doses .
Pain, postoperative:
Continuous infusion, 8 to 16 mg of 0.2% (2 mg per mL) solutionper hour .
Local infiltration-
Pain, postoperative-
2 to 200 mg of 0.2% (2 mg per mL) solution or 5 to 200 mg of 0.5% (5 mg per mL) solution, administered in incremental doses .
Peripheral nerve block-
Anesthesia, surgical-
Field block-5 to 200 mg of 0.5% (5 mg per mL) solution , administered in incremental doses .
Major nerve block-175 to 250 mgof 0.5% (5 mg per mL) solution , administered in incremental doses . |
|
MAXIMUM ADULT DOSE:
|
|
|
|
PEDIATRIC DOSE:
|
|
Children up to 12 years of age-Safety and efficacy have not been established . |
|
MAXIMUM PEDIATRIC
DOSE:
|
|
|
|
ELDERLY DOSE:
|
|
Central neural blocks-
Lumbar epidural-
Anesthesia, surgical:
75 to 150 mg of 0.5% (5 mg per mL) solution, administered in incremental doses.
113 to 188 mg of 0.75% (7.5 mg per mL) solution, administered in incremental doses.
150 to 200 mg of 1% (10 mg per mL) solution, administered in incremental doses.
Anesthesia, surgical, cesarean section:
100 to 150 mg of 0.5% (5 mg per mL) solution, administered in incremental doses .
Pain, obstetrical:
20 to 40 mg of 0.2% (2 mg per mL) solution initially, then 12 to 28 mg per hour as a continuous infusion or 20 to 30 mg per hour, administered in incremental doses .
Pain, postoperative:
Continuous infusion, 12 to 20 mg of 0.2% (2 mg per mL) solution per hour .
Thoracic epidural-
Anesthesia, surgical:
25 to 75 mg of 0.5% (5 mg per mL) solution, administered in incremental doses .
Pain, postoperative:
Continuous infusion, 8 to 16 mg of 0.2% (2 mg per mL) solutionper hour .
Local infiltration-
Pain, postoperative-
2 to 200 mg of 0.2% (2 mg per mL) solution or 5 to 200 mg of 0.5% (5 mg per mL) solution, administered in incremental doses .
Peripheral nerve block-
Anesthesia, surgical-
Field block-5 to 200 mg of 0.5% (5 mg per mL) solution , administered in incremental doses .
Major nerve block-175 to 250 mgof 0.5% (5 mg per mL) solution , administered in incremental doses . |
|
|
|
|
|